Adipose Derived Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064098
  • May 2021
  • Biotechnology
  • 129 Pages
The Adipose Derived Stem Cell Therapy market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Adipose Derived Stem Cell Therapy market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered AlloCure, Inc, Antria, Inc., Celgene Corporation, Cellleris SA, Corestem, Inc., Cytori Therapeutics, LLC, Intrexon, Inc., Mesoblast Ltd., Pluristem Therapeutics, Inc., Tissue Genesis, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Adipose Derived Stem Cell Therapy market along with their effects over the forecast period. Similarly, according to the region Adipose Derived Stem Cell Therapy market research report includes the study of opportunities available in the market situation.

The Adipose Derived Stem Cell Therapy market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Adipose Derived Stem Cell Therapy Market:
The Adipose Derived Stem Cell Therapy market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. AlloCure, Inc, Antria, Inc., Celgene Corporation, Cellleris SA, Corestem, Inc., Cytori Therapeutics, LLC, Intrexon, Inc., Mesoblast Ltd., Pluristem Therapeutics, Inc., Tissue Genesis, Inc.

Adipose Derived Stem Cell Therapy Market Segmentation Analysis:
By Cell Type
Autologous Stem Cells
Allogeneic Stem Cells
Product
Cell Line
Culture Media
Disease
Cancer
Obesity
Wounds and Injuries
Musculoskeletal Diseases
Cardiovascular Diseases
Others
End User
Hospitals and Trauma Centers
Cell banks and Tissue Banks
Research Laboratories and Academic Institutes
Others

Global Adipose Derived Stem Cell Therapy Market Segmentation by Regions:
In regional analysis, Adipose Derived Stem Cell Therapy market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Adipose Derived Stem Cell Therapy market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Adipose Derived Stem Cell Therapy Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Adipose Derived Stem Cell Therapy Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Adipose Derived Stem Cell Therapy Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Adipose Derived Stem Cell Therapy Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Adipose Derived Stem Cell Therapy Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Adipose Derived Stem Cell Therapy market, according to the key region.
  • To study the Adipose Derived Stem Cell Therapy market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Adipose Derived Stem Cell Therapy market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Adipose Derived Stem Cell Therapy research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Adipose Derived Stem Cell Therapy market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Adipose Derived Stem Cell Therapy market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Adipose Derived Stem Cell Therapy market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Adipose Derived Stem Cell Therapy market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Adipose Derived Stem Cell Therapy market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • AlloCure, Inc
  • Antria, Inc.
  • Celgene Corporation
  • Cellleris SA
  • Corestem, Inc.
  • Cytori Therapeutics, LLC
  • Intrexon, Inc.
  • Mesoblast Ltd.
  • Pluristem Therapeutics, Inc.
  • Tissue Genesis, Inc.
  • Autologous Stem Cells
  • Allogeneic Stem Cells
  • Hospitals and Trauma Centers
  • Cell banks and Tissue Banks
  • Research Laboratories and Academic Institutes
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Adipose Derived Stem Cell Therapy Market Snapshot
          2.1.1. Global Adipose Derived Stem Cell Therapy Market By Cell Type,2019
               2.1.1.1.Autologous Stem Cells
               2.1.1.2.Allogeneic Stem Cells
          2.1.2. Global Adipose Derived Stem Cell Therapy Market By End User,2019
               2.1.2.1.Hospitals and Trauma Centers
               2.1.2.2.Cell banks and Tissue Banks
               2.1.2.3.Research Laboratories and Academic Institutes
               2.1.2.4.Others
          2.1.3. Global Adipose Derived Stem Cell Therapy Market By End-use,2019
          2.1.4. Global Adipose Derived Stem Cell Therapy Market By Geography,2019

3. Global Adipose Derived Stem Cell Therapy Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Cell Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Cell Type, 2020
     4.2. Global Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028

5. Global Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028

6. Global Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028

7. Global Adipose Derived Stem Cell Therapy Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Adipose Derived Stem Cell Therapy Market Analysis, 2018 – 2028 
          7.2.1. North America Adipose Derived Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028
          7.2.3. North America Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Adipose Derived Stem Cell Therapy Market Analysis, 2018 – 2028 
          7.3.1.  Europe Adipose Derived Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028
          7.3.3. Europe Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Adipose Derived Stem Cell Therapy Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Adipose Derived Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028
          7.4.3. Asia Pacific Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Adipose Derived Stem Cell Therapy Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Adipose Derived Stem Cell Therapy Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028
          7.5.3. Latin America Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Adipose Derived Stem Cell Therapy Market Analysis, 2018 – 2028 
          7.6.1.  MEA Adipose Derived Stem Cell Therapy Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Adipose Derived Stem Cell Therapy Market Size (US$), By Cell Type, 2018 – 2028
          7.6.3. MEA Adipose Derived Stem Cell Therapy Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Adipose Derived Stem Cell Therapy Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Adipose Derived Stem Cell Therapy Providers
        8.4.1 AlloCure, Inc
                8.4.1.1 Business Description
                8.4.1.2 AlloCure, Inc Geographic Operations
                8.4.1.3 AlloCure, Inc Financial Information
                8.4.1.4 AlloCure, Inc Product Positions/Portfolio
                8.4.1.5 AlloCure, Inc Key Developments
        8.4.2 Antria, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Antria, Inc. Geographic Operations
                8.4.2.3 Antria, Inc. Financial Information
                8.4.2.4 Antria, Inc. Product Positions/Portfolio
                8.4.2.5 Antria, Inc. Key Developments
        8.4.3 Celgene Corporation
                8.4.3.1 Business Description
                8.4.3.2 Celgene Corporation Geographic Operations
                8.4.3.3 Celgene Corporation Financial Information
                8.4.3.4 Celgene Corporation Product Positions/Portfolio
                8.4.3.5 Celgene Corporation Key Developments
        8.4.4 Cellleris SA
                8.4.4.1 Business Description
                8.4.4.2 Cellleris SA Geographic Operations
                8.4.4.3 Cellleris SA Financial Information
                8.4.4.4 Cellleris SA Product Positions/Portfolio
                8.4.4.5 Cellleris SA Key Developments
        8.4.5 Corestem, Inc.
                8.4.5.1 Business Description
                8.4.5.2 Corestem, Inc. Geographic Operations
                8.4.5.3 Corestem, Inc. Financial Information
                8.4.5.4 Corestem, Inc. Product Positions/Portfolio
                8.4.5.5 Corestem, Inc. Key Developments
        8.4.6 Cytori Therapeutics, LLC
                8.4.6.1 Business Description
                8.4.6.2 Cytori Therapeutics, LLC Geographic Operations
                8.4.6.3 Cytori Therapeutics, LLC Financial Information
                8.4.6.4 Cytori Therapeutics, LLC Product Positions/Portfolio
                8.4.6.5 Cytori Therapeutics, LLC Key Developments
        8.4.7 Intrexon, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Intrexon, Inc. Geographic Operations
                8.4.7.3 Intrexon, Inc. Financial Information
                8.4.7.4 Intrexon, Inc. Product Positions/Portfolio
                8.4.7.5 Intrexon, Inc. Key Developments
        8.4.8 Mesoblast Ltd.
                8.4.8.1 Business Description
                8.4.8.2 Mesoblast Ltd. Geographic Operations
                8.4.8.3 Mesoblast Ltd. Financial Information
                8.4.8.4 Mesoblast Ltd. Product Positions/Portfolio
                8.4.8.5 Mesoblast Ltd. Key Developments
        8.4.9 Pluristem Therapeutics, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Pluristem Therapeutics, Inc. Geographic Operations
                8.4.9.3 Pluristem Therapeutics, Inc. Financial Information
                8.4.9.4 Pluristem Therapeutics, Inc. Product Positions/Portfolio
                8.4.9.5 Pluristem Therapeutics, Inc. Key Developments
        8.4.10 Tissue Genesis, Inc.
                8.4.10.1 Business Description
                8.4.10.2 Tissue Genesis, Inc. Geographic Operations
                8.4.10.3 Tissue Genesis, Inc. Financial Information
                8.4.10.4 Tissue Genesis, Inc. Product Positions/Portfolio
                8.4.10.5 Tissue Genesis, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Adipose Derived Stem Cell Therapy Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Adipose Derived Stem Cell Therapy Market Revenue, By Cell Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Adipose Derived Stem Cell Therapy Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Adipose Derived Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Adipose Derived Stem Cell Therapy Market Revenue, By Cell Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Adipose Derived Stem Cell Therapy Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Adipose Derived Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Adipose Derived Stem Cell Therapy Market Revenue, By Cell Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Adipose Derived Stem Cell Therapy Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Adipose Derived Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Adipose Derived Stem Cell Therapy Market Revenue, By Cell Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Adipose Derived Stem Cell Therapy Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Adipose Derived Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Adipose Derived Stem Cell Therapy Market Revenue, By Cell Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Adipose Derived Stem Cell Therapy Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Adipose Derived Stem Cell Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Adipose Derived Stem Cell Therapy: Market Segmentation 
FIG. 2 Global Adipose Derived Stem Cell Therapy Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Adipose Derived Stem Cell Therapy Market, By Cell Type, 2019 (US$ Mn) 
FIG. 5 Global Adipose Derived Stem Cell Therapy Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Adipose Derived Stem Cell Therapy Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Adipose Derived Stem Cell Therapy Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Adipose Derived Stem Cell Therapy Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Adipose Derived Stem Cell Therapy Providers, 2019
FIG. 11 Global Adipose Derived Stem Cell Therapy Market Revenue Contribution, By Cell Type, 2019 & 2028 (Value %) 
FIG. 12 Global Adipose Derived Stem Cell Therapy Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Adipose Derived Stem Cell Therapy Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Adipose Derived Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Adipose Derived Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Adipose Derived Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Adipose Derived Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Adipose Derived Stem Cell Therapy Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Adipose Derived Stem Cell Therapy market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Adipose Derived Stem Cell Therapy Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Adipose Derived Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE  North America Adipose Derived Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE  North America Adipose Derived Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE  Europe Adipose Derived Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE  Europe Adipose Derived Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE  Europe Adipose Derived Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Adipose Derived Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Adipose Derived Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Adipose Derived Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE  Latin America Adipose Derived Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Adipose Derived Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Adipose Derived Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE  MEA Adipose Derived Stem Cell Therapy Market Value, By Segment1, 2018 – 2028
TABLE  MEA Adipose Derived Stem Cell Therapy Market Value, By Segment2, 2018 – 2028
TABLE  MEA Adipose Derived Stem Cell Therapy Market Value, By Country, 2018 – 2028
TABLE  AlloCure, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Antria, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celgene Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cellleris SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Corestem, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cytori Therapeutics, LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Intrexon, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mesoblast Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pluristem Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tissue Genesis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Adipose Derived Stem Cell Therapy Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Adipose Derived Stem Cell Therapy Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Adipose Derived Stem Cell Therapy Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Adipose Derived Stem Cell Therapy Market, By Geography, 2019 (US$ Mn)
FIG.  Global Adipose Derived Stem Cell Therapy Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Adipose Derived Stem Cell Therapy Providers, 2016
FIG.  Global Adipose Derived Stem Cell Therapy Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Allogeneic Stem Cells Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Adipose Derived Stem Cell Therapy Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Cell banks and Tissue Banks Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Research Laboratories and Academic Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Adipose Derived Stem Cell Therapy Market Value, 2018 – 2028, (US$ Mn)